Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Dermatologicals Market Segmentation
1. Executive Summary
2. Global Dermatology Drugs Introduction
2.1. Global Dermatology Drugs – Taxonomy
2.2. Global Dermatology Drugs –Definitions
2.2.1. By Drug Class
2.2.2. By Indication
2.2.3. By Route of Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Dermatology Drugs Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermatology Drugs Dynamic Factors - Impact Analysis
3.6. Global Dermatology Drugs – Competition Landscape
3.7. Epidemiology
4. Global Dermatology Drugs Analysis,2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Dermatology Drugs, By Drug Class, 2018–2022and Forecast, 2023–2029 (Revenue, USD Mn)
5.1. Anti-infectives
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Corticosteroids
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Anti-acne
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Calcineurin Inhibitors
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Retinoids
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Dermatology Drugs, By Indication, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
6.1. Acne
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Dermatitis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Psoriasis
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Skin Cancer
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Rosacea
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Alopecia
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Dermatology Drugs Forecast, By Route of Administration, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
7.1. Oral
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Topical
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Dermatology Drugs, By Distribution Channel, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Dermatology Drugs Forecast, By Region, 2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Region, 2023 - 2029
10. North America Dermatology DrugsAnalysis,2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
10.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Anti-infectives
10.1.2. Corticosteroids
10.1.3. Anti-acne
10.1.4. Calcineurin Inhibitors
10.1.5. Retinoids
10.1.6. Others
10.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Acne
10.2.2. Dermatitis
10.2.3. Psoriasis
10.2.4. Skin Cancer
10.2.5. Rosacea
10.2.6. Alopecia
10.2.7. Others
10.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Topical
10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
10.7. North America Dermatology Drugs Dynamics – Trends
11. Europe Dermatology Drugs Analysis, 2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
11.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Anti-infectives
11.1.2. Corticosteroids
11.1.3. Anti-acne
11.1.4. Calcineurin Inhibitors
11.1.5. Retinoids
11.1.6. Others
11.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Acne
11.2.2. Dermatitis
11.2.3. Psoriasis
11.2.4. Skin Cancer
11.2.5. Rosacea
11.2.6. Alopecia
11.2.7. Others
11.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Topical
11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Country Analysis 2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
11.7. Europe Dermatology Drugs Dynamics – Trends
12. Asia-Pacific Dermatology Drugs Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Anti-infectives
12.1.2. Corticosteroids
12.1.3. Anti-acne
12.1.4. Calcineurin Inhibitors
12.1.5. Retinoids
12.1.6. Others
12.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Acne
12.2.2. Dermatitis
12.2.3. Psoriasis
12.2.4. Skin Cancer
12.2.5. Rosacea
12.2.6. Alopecia
12.2.7. Others
12.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parenteral
12.3.3. Topical
12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Country Analysis2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country,2023 - 2029
12.7. Asia-Pacific Dermatology Drugs Dynamics – Trends
13. Latin America Dermatology Drugs Analysis,2018 - 2022 and Forecast, 2023–2029(Revenue, USD Mn)
13.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Anti-infectives
13.1.2. Corticosteroids
13.1.3. Anti-acne
13.1.4. Calcineurin Inhibitors
13.1.5. Retinoids
13.1.6. Others
13.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Acne
13.2.2. Dermatitis
13.2.3. Psoriasis
13.2.4. Skin Cancer
13.2.5. Rosacea
13.2.6. Alopecia
13.2.7. Others
13.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parenteral
13.3.3. Topical
13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Country Analysis 2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
13.7. Latin America Dermatology Drugs Dynamics – Trends
14. Middle East and Africa Dermatology Drugs Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Anti-infectives
14.1.2. Corticosteroids
14.1.3. Anti-acne
14.1.4. Calcineurin Inhibitors
14.1.5. Retinoids
14.1.6. Others
14.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Acne
14.2.2. Dermatitis
14.2.3. Psoriasis
14.2.4. Skin Cancer
14.2.5. Rosacea
14.2.6. Alopecia
14.2.7. Others
14.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parenteral
14.3.3. Topical
14.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
14.7. MEA Dermatology Drugs Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Class& Service Indication, Key Developments, Strategies, and SWOT Analysis)
15.2.1. GlaxoSmithKline Plc.
15.2.2. Johnson & Johnson Services Inc
15.2.3. Leo Pharma A/S
15.2.4. Novartis AG
15.2.5. Pfizer Inc.
15.2.6. Sun Pharmaceutical Industries Limited.
15.2.7. Viatris
15.2.8. Eli Lilly and Company
15.2.9. Allergan plc
15.2.10. Sanofi S.A.
16. Research Methodology
17. Key Assumptions and Acronyms
2. Global Dermatology Drugs Introduction
2.1. Global Dermatology Drugs – Taxonomy
2.2. Global Dermatology Drugs –Definitions
2.2.1. By Drug Class
2.2.2. By Indication
2.2.3. By Route of Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Dermatology Drugs Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermatology Drugs Dynamic Factors - Impact Analysis
3.6. Global Dermatology Drugs – Competition Landscape
3.7. Epidemiology
4. Global Dermatology Drugs Analysis,2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Dermatology Drugs, By Drug Class, 2018–2022and Forecast, 2023–2029 (Revenue, USD Mn)
5.1. Anti-infectives
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Corticosteroids
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Anti-acne
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Calcineurin Inhibitors
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Retinoids
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Dermatology Drugs, By Indication, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
6.1. Acne
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Dermatitis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Psoriasis
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Skin Cancer
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Rosacea
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Alopecia
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Dermatology Drugs Forecast, By Route of Administration, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
7.1. Oral
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Topical
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Dermatology Drugs, By Distribution Channel, 2018 – 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Dermatology Drugs Forecast, By Region, 2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Region, 2023 - 2029
10. North America Dermatology DrugsAnalysis,2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
10.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Anti-infectives
10.1.2. Corticosteroids
10.1.3. Anti-acne
10.1.4. Calcineurin Inhibitors
10.1.5. Retinoids
10.1.6. Others
10.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Acne
10.2.2. Dermatitis
10.2.3. Psoriasis
10.2.4. Skin Cancer
10.2.5. Rosacea
10.2.6. Alopecia
10.2.7. Others
10.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Topical
10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
10.7. North America Dermatology Drugs Dynamics – Trends
11. Europe Dermatology Drugs Analysis, 2018–2022and Forecast, 2023–2029(Revenue, USD Mn)
11.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Anti-infectives
11.1.2. Corticosteroids
11.1.3. Anti-acne
11.1.4. Calcineurin Inhibitors
11.1.5. Retinoids
11.1.6. Others
11.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Acne
11.2.2. Dermatitis
11.2.3. Psoriasis
11.2.4. Skin Cancer
11.2.5. Rosacea
11.2.6. Alopecia
11.2.7. Others
11.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Topical
11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Country Analysis 2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
11.7. Europe Dermatology Drugs Dynamics – Trends
12. Asia-Pacific Dermatology Drugs Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Anti-infectives
12.1.2. Corticosteroids
12.1.3. Anti-acne
12.1.4. Calcineurin Inhibitors
12.1.5. Retinoids
12.1.6. Others
12.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Acne
12.2.2. Dermatitis
12.2.3. Psoriasis
12.2.4. Skin Cancer
12.2.5. Rosacea
12.2.6. Alopecia
12.2.7. Others
12.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parenteral
12.3.3. Topical
12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Country Analysis2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country,2023 - 2029
12.7. Asia-Pacific Dermatology Drugs Dynamics – Trends
13. Latin America Dermatology Drugs Analysis,2018 - 2022 and Forecast, 2023–2029(Revenue, USD Mn)
13.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Anti-infectives
13.1.2. Corticosteroids
13.1.3. Anti-acne
13.1.4. Calcineurin Inhibitors
13.1.5. Retinoids
13.1.6. Others
13.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Acne
13.2.2. Dermatitis
13.2.3. Psoriasis
13.2.4. Skin Cancer
13.2.5. Rosacea
13.2.6. Alopecia
13.2.7. Others
13.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parenteral
13.3.3. Topical
13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Country Analysis 2018–2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
13.7. Latin America Dermatology Drugs Dynamics – Trends
14. Middle East and Africa Dermatology Drugs Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Drug Class Analysis 2018–2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Anti-infectives
14.1.2. Corticosteroids
14.1.3. Anti-acne
14.1.4. Calcineurin Inhibitors
14.1.5. Retinoids
14.1.6. Others
14.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Acne
14.2.2. Dermatitis
14.2.3. Psoriasis
14.2.4. Skin Cancer
14.2.5. Rosacea
14.2.6. Alopecia
14.2.7. Others
14.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parenteral
14.3.3. Topical
14.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Dermatology Drugs - Opportunity Analysis Index, By Drug Class, Indication, Indication, Route of Administration, Distribution Channel, and Country, 2023 - 2029
14.7. MEA Dermatology Drugs Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Class& Service Indication, Key Developments, Strategies, and SWOT Analysis)
15.2.1. GlaxoSmithKline Plc.
15.2.2. Johnson & Johnson Services Inc
15.2.3. Leo Pharma A/S
15.2.4. Novartis AG
15.2.5. Pfizer Inc.
15.2.6. Sun Pharmaceutical Industries Limited.
15.2.7. Viatris
15.2.8. Eli Lilly and Company
15.2.9. Allergan plc
15.2.10. Sanofi S.A.
16. Research Methodology
17. Key Assumptions and Acronyms
• GlaxoSmithKline Plc.
• Johnson & Johnson Services Inc
• Leo Pharma A/S
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Limited
• Viatris
• Eli Lilly and Company
• Allergan plc
• Sanofi S.A.
• Bayer AG
• Johnson & Johnson Services Inc
• Leo Pharma A/S
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Limited
• Viatris
• Eli Lilly and Company
• Allergan plc
• Sanofi S.A.
• Bayer AG